Mutation pattern in human adrenoleukodystrophy protein in terms of amino-acid pair predictability
Shao-Min Yan, Guang Wu
DOI: 10.4236/jbise.2010.33035   PDF   HTML     5,214 Downloads   8,494 Views   Citations


The mutation pattern in protein is a very important feature and is studied through various approaches including the study on mutation pattern in domains where amino acids are converted into numbers from letters. In this study, we converted the amino acids in human adrenoleukodystrophy protein with its 128 missense mutations into random domain using the amino-acid pair predictability, and then we studied their mutation patterns. The results show 1) the mutations are more likely to target the amino-acid pairs whose actual frequency is larger than their predicted one, 2) the mutations are more likely to form the amino-acid pairs whose actual frequency is smaller than their predicted frequency, 3) mutations are more likely to occur at unpredictable amino-acid pairs, and 4) mutations have the trend to narrow the difference between predicted and actual frequencies of amino-acid pairs.

Share and Cite:

Yan, S. and Wu, G. (2010) Mutation pattern in human adrenoleukodystrophy protein in terms of amino-acid pair predictability. Journal of Biomedical Science and Engineering, 3, 262-267. doi: 10.4236/jbise.2010.33035.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Rideout, W.M., Coetzee, G.A., Olumi, A.F. and Jones, P.A. (1990) 5-Methylcytosine as an endogenous mutagen in human LL receptor and p53 genes. Science, 249, 1288-1290.
[2] Montesano, R., Hainaut, P. and Wild, C.P. (1997) Hepatocellular carcinoma: From gene to public health. Journal of the National Cancer Institute, 89, 1844-1851.
[3] Hainaut, P. and Pfeifer, G.P. (2001) Patterns of p53 G?T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis, 22, 367-374.
[4] Fasman, G.D. (1976) Handbook of biochemistry: Section D physical chemical data. 3rd Edition, CRC Press, London and New York.
[5] Wu, G., and Yan, S. (2002) Randomness in the primary structure of protein: methods and implications. Molecular Biology Today, 3, 55-69.
[6] Wu, G. and Yan, S. (2006) Mutation trend of hemagglutinin of influenza A virus: A review from computational mutation viewpoint. Acta Pharmacologica Sinica, 27, 513-526.
[7] Wu, G. and Yan, S. (2006) Fate of influenza A virus proteins. Protein and Peptide Letters, 13, 377-384.
[8] Wu, G. and Yan, S. (2008) Lecture Notes on Computational Mutation. Nova Science Publishers, New York.
[9] Everitt, B.S. (1999) Chance rules: An informal guide to probability, risk, and statistics. Springer, New York.
[10] Efferth, T. (2001) The human ATP-binding cassette transporter genes: From the bench to the bedside. Current Molecular Medicine, 1, 45-65.
[11] Pohl, A., Devaux, P.F. and Herrmann, A. (2005) Function of prokaryotic and eukaryotic ABC proteins in lipid transport. Biochimica and Biophysica Acta, 1733, 29-52.
[12] Oswald, C., Holland, I.B. and Schmitt, L. (2006) The motor domains of ABC-transporters. What can structures tell us? Naunyn-Schmiedeberg's Archives of Pharmacology, 372, 385-399.
[13] Kim, J.H. and Kim, H.J. (2005) Childhood X-linked adrenoleukodystrophy: Clinical-pathologic overview and MR imaging manifestations at initial evaluation and follow-up. Radiographics, 25, 619-631.
[14] Shimozawa, N. (2007) Molecular and clinical aspects of peroxisomal diseases. Journal of inherited metabolic disease, 30, 193-197.
[15] Wanders, R.J., Visser, W.F., van Roermund, S., Kemp, C.W. and Waterham, H.R. (2007) The peroxisomal ABC transporter family. Pflügers Archiv European Journal of Physiology, 453, 719-734.
[16] Moser, H., Dubey, P. and Fatemi, A. (2004) Progress in X-linked adrenoleukodystrophy. Current opinion in neurology, 17, 263-269.
[17] Moser, H.W., Mahmood, A. and Raymond, G.V. (2007) X-linked adrenoleukodystrophy. Nature Clinical Practice. Neurology, 3, 140-151.
[18] Wanders, R.J. and Waterham, H.R. (2005) Peroxisomal disorders I: Biochemistry and genetics of peroxisome biogenesis disorders. Clinical Genetics, 67, 107-133.
[19] Bezman, L., Moser, A.B., Raymond, G.V., Rinaldo, P., Watkins, P.A., Smith, K.D., Kass, N.E. and Moser, H.W. (2001) Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening. Annals of Neurol, 49, 512-517.
[20] Elgersma, Y. and Tabak, H.F. (1996) Proteins involved in peroxisome biogenesis and functioning. Biochimica and Biophysica Acta, 1286, 269-283.
[21] Hettema, E.H. and Tabak, H.F. (2000) Transport of fatty acids and metabolites across the peroxisomal membrane. Biochimica and Biophysica Acta, 1486, 18-27.
[22] Clayton, P.T. (2001) Clinical consequences of defects in peroxisomal beta-oxidation. Biochemical Society Transactions, 29, 298-305.
[23] Hargrove, J.L., Greenspan, P. and Hartle, D.K. (2004) Nutritional significance and metabolism of very long chain fatty alcohols and acids from dietary waxes. Experimental Biology and Medicine, 229, 215-226.
[24] Kemp, S. and Wanders, R.J. (2007) X-linked adrenoleukodystrophy: Very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Molecular Genetics and Metabolism, 90, 268-276.
[25] Takano, H., Koike, R., Onodera, O. and Tsuji, S. (2000) Mutational analysis of X-linked adrenoleukodystrophy gene. Cell Biochemistry and Biophysics, 32, 177-185.
[26] Berger, J. and G?rtner, J. (2006) X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects. Biochimica and Biophysica Acta, 1763, 1721- 1732.
[27] Kemp, S., Pujol, A., Waterham, H.R., van Geel, B.M., Boehm, C.D., Raymond, G.V., Cutting, G.R., Wanders, R.J.A. and Moser, H.W. (2001) ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations. Human Mutation, 18, 499-515.
[28] Bairoch, A. and Apweiler, R. (2000) The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 2000. Nucleic Acids Research, 28, 45-48.
[29] Wu, G. (1999) The first and second order Markov chain analysis on amino acids sequence of human haemoglobin -chain and its three variants with low O2 affinity. Comparative Haematology International, 9, 148-151.
[30] Wu, G. (2000) The first, second, third and fourth order Markov chain analysis on amino acids sequence of human dopamine-hydroxylase. Molecular Psychiatry, 5, 448-451.
[31] Wu, G. and Yan, S.M. (2001) Prediction of presence and absence of two- and three-amino-acid sequence of human monoamine oxidase B from its amino acid composition according to the random mechanism. Biomolecular Engineering, 18, 23-27.
[32] Wu, G. and Yan, S.M. (2002) Estimation of amino acid pairs sensitive to variants in human phenylalanine hydroxylase protein by means of a random approach. Peptides, 23, 2085-2090.
[33] Wu, G. and Yan, S. (2003) Determination of amino acid pairs sensitive to variants in human-glucocerebrosidase by means of a random approach. Protein Engineering Design and Selection, 16, 195-199.
[34] Wu, G. and Yan, S. (2004) Fate of 130 hemagglutinins from different influenza A viruses. Biochemical and BioPhysical Research Communications, 317, 917-924
[35] Wu, G. and Yan, S. (2005) Prediction of mutation trend in hemagglutinins and neuraminidases from influenza A viruses by means of cross-impact analysis. Biochemical and Bio-Physical Research Communications, 326, 475-482.
[36] Wu, G. and Yan, S. (2006) Timing of mutation in hemagglutinins from influenza A virus by means of amino-acid distribution rank and fast Fourier transform. Protein and Peptide Letters, 13, 143-148.
[37] Wu, G. and Yan, S. (2007) Prediction of mutations in H1 neuraminidases from North America influenza A virus engineered by internal randomness. Molecular Diversity, 11, 131-140.
[38] Wu, G. and Yan, S. (2008) Prediction of mutations engineered by randomness in H5N1 neuraminidases from influenza A virus. Amino Acids, 34, 81-90.
[39] Yan, S. and Wu, G. (2009) Describing evolution of hemagglutinins from influenza A viruses using a differential equation. Protein and Peptide Letters, 16, 794-804.
[40] Zhou, H.X. (2004) Improving the understanding of human genetic diseases through predictions of protein structures and protein-protein interaction sites. Current Medicinal Chemistry, 11, 539-549.
[41] Kuvaniemi, H., Tromp, G. and Prockop, D.J. (1997) Mutations in fibrillar collagens (types I, II, III, and IV), fibril-associated collagen (type IV), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Human Mutation, 9, 300-315.
[42] Kashtan, C.E. (2000) Alport syndromes: Phenotypic heterogeneity of progressive hereditary nephritis. Pediatric Nephrology, 14, 502-512.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.